Moderna vaccine approved for 12- to 17-year-olds

Pharmacists to be paid less for autumn Covid boosters

The UK’s medicines regulator has approved the Moderna Covid vaccine for children aged 12- to 17-years-old.

The Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed today (17 August) that the vaccine is ‘safe and effective’ for the age group.

Related Article: Beyond the scales: reframing eating disorder recognition in primary care

At the start of this month, NHS England instructed clinics to begin vaccinating all 16- to 17-year-olds and 12- to 15-year-olds deemed to be at risk.

The MHRA today said that it is now down to the Joint Committee on Vaccination and Immunisation (JCVI) to advise on its use as part of the vaccine programme, alongside the Pfizer/BioNTech shot.

Dr June Raine, MHRA chief executive, said: ‘I am pleased to confirm that that the Covid-19 vaccine made by Moderna has now been authorised in 12– to 17-year-olds. The vaccine is safe and effective in this age group.

Related Article: Sharp rise in diabetes cases prompts call for better postnatal support

‘We have in place a comprehensive safety surveillance strategy for monitoring the safety of all UK-approved Covid-19 vaccines and this surveillance will include the 12- to 17-year age group.’

It comes after a Public Health England funded study found that two doses of the Pfizer or AstraZeneca Covid vaccines are necessary for good protection against the delta variant.

Related Article: Novo Nordisk launch new 7.2mg single-dose Wegovy pen

The research, published in the New England Journal of Medicine, reported that a two-dose regimen of the Pfizer vaccine was 88% effective against symptomatic disease caused by the delta variant. A two-dose course of the AstraZeneca jab was also found to be 67% effective against symptomatic disease.

A version of this story was first published on our sister title Healthcare Leader.

Keep your clinical knowledge up to date with The Pharmacist
Extend your learning and record your learning outcomes
Want news like this straight to your inbox?
Register for full access to the site and our bulletins
Have your say

Leave a Reply

Your email address will not be published. Required fields are marked *

Please add your comment in the box below. You can include links, but HTML is not permitted. Please note that comments are not moderated before publication and the views expressed are those of the user and do not reflect the views of The Pharmacist. Remember that submission of comments is governed by our Terms and Conditions. You can also read our full guidelines on article comments here – but please be aware that you are legally liable for any libellous or offensive comments that you make. If you have a complaint about a comment or are concerned that a comment breaches our terms and conditions, please use the ‘Report this comment’ function to alert our web team.